9-phenyl-2-(4-pyridin-2-ylpiperazin-1-yl)-N-[[3-(trifluoromethyl)phenyl]methyl]purin-6-amine
C28H25F3N8 — CID 117089389
Data last refreshed: (MolForge compound catalog, from PubChem)
About 9-phenyl-2-(4-pyridin-2-ylpiperazin-1-yl)-N-[[3-(trifluoromethyl)phenyl]methyl]purin-6-amine
9-phenyl-2-(4-pyridin-2-ylpiperazin-1-yl)-N-[[3-(trifluoromethyl)phenyl]methyl]purin-6-amine (PubChem CID 117089389) has the molecular formula C28H25F3N8 and a molecular weight of 530.56 g/mol. Its IUPAC name is 9-phenyl-2-(4-pyridin-2-ylpiperazin-1-yl)-N-[[3-(trifluoromethyl)phenyl]methyl]purin-6-amine.
Molecular Properties
| Compound Name | 9-phenyl-2-(4-pyridin-2-ylpiperazin-1-yl)-N-[[3-(trifluoromethyl)phenyl]methyl]purin-6-amine |
|---|---|
| PubChem CID | 117089389 |
| Molecular Formula | C28H25F3N8 |
| Molecular Weight | 530.56 g/mol |
| Exact Mass | 530.22 |
| IUPAC Name | 9-phenyl-2-(4-pyridin-2-ylpiperazin-1-yl)-N-[[3-(trifluoromethyl)phenyl]methyl]purin-6-amine |
| SMILES | FC(F)(F)c1cccc(CNc2nc(N3CCN(c4ccccn4)CC3)nc3c2ncn3-c2ccccc2)c1 |
| InChI | InChI=1S/C28H25F3N8/c29-28(30,31)21-8-6-7-20(17-21)18-33-25-24-26(39(19-34-24)22-9-2-1-3-10-22)36-27(35-25)38-15-13-37(14-16-38)23-11-4-5-12-32-23/h1-12,17,19H,13-16,18H2,(H,33,35,36) |
| InChIKey | XIMVQAFVZFGFIC-UHFFFAOYSA-N |
| XLogP | 5.17 |
| TPSA | 75.00 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 39 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 530.56 |
| LogP ≤ 5 | 5.17 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 117089389 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.